Novel CRBN-Recruiting Proteolysis-Targeting Chimeras as Degraders of Stimulator of Interferon Genes with In Vivo Anti-Inflammatory EfficacyJin Liu, Jianjun Chen, L. Yuan et al.|Journal of Medicinal Chemistry|2022Cited by 94
Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activityLing Li, Yinrong Wu, Zichao Yang et al.|Bioorganic Chemistry|2021Cited by 40
Biosynthetic molecular imaging probe for tumor-targeted dual-modal fluorescence/magnetic resonance imagingHuaixin Zhao, Dayong Yang, Huiting Zhao et al.|Biomaterials|2020Cited by 39
<p>The Effect of Size, Dose, and Administration Route on Zein Nanoparticle Immunogenicity in BALB/c Mice</p>Feng Li, Yong Zhang, Yan Chen et al.|International Journal of Nanomedicine|2019Cited by 31
Discovery of Thieno[2,3-d]pyrimidine-based KRAS G12D inhibitors as potential anticancer agents via combinatorial virtual screeningLing Li, Jianjun Chen, Jin Liu et al.|European Journal of Medicinal Chemistry|2022Cited by 29